Angioni S (2017) New insights on endometriosis. Minerva Ginecol 69(5):438–439. https://doi.org/10.23736/S0026-4784.17.04089-8
2.Pontis A, Arena I, Angioni S (2014) Umbilical endometriosis primary site without pelvic endometriosis and previous surgery: a case report. G Ital di Ostet e Ginecol 36:336–338. https://doi.org/10.11138/giog/2014.36.2.336
3.Eisenberg VH, Weil C, Chodick G, Shalev V (2018) Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members. BJOG An Int J Obstet Gynaecol 125(1):55–62. https://doi.org/10.1111/1471-0528.14711
4.Stochino-Loi E, Millochau J-C, Angioni S et al (2020) Relationship between patient age and disease features in a prospective cohort of 1560 women affected by endometriosis. J Minim Invasive Gynecol 27(5):1158–1166. https://doi.org/10.1016/j.jmig.2019.09.004
5.Melis I, Agus M, Pluchino N et al (2014) Alexithymia in women with deep endometriosis? A pilot study. J Endometr 6(1):26–33. https://doi.org/10.5301/je.5000172
6.Melis I, Litta P, Nappi L et al (2015) Sexual function in women with deep endometriosis: correlation with quality of life, intensity of pain, depression, anxiety, and body image. Int J Sex Health 27. https://doi.org/10.1080/19317611.2014.952394
7.Angioni S, Cela V, Sedda F et al (2015) Focusing on surgery results in infertile patients with deep endometriosis. Gynecol Endocrinol 31(8):595–598. https://doi.org/10.3109/09513590.2015.1062868
8.Alio L, Angioni S, Arena S et al (2019) Endometriosis: seeking optimal management in women approaching menopause. Climacteric 22(4):329–338. https://doi.org/10.1080/13697137.2018.1549213
CAS Article PubMed Google Scholar
9.Stochino-Loi E, Darwish B, Mircea O et al (2017) Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis? Fertil Steril 107(3):707–713.e3. https://doi.org/10.1016/j.fertnstert.2016.12.013
CAS Article PubMed Google Scholar
10.Deiana D, Gessa S, Anardu M et al (2019) Genetics of endometriosis: a comprehensive review. Gynecol Endocrinol 35:553–558. https://doi.org/10.1080/09513590.2019.1588244
CAS Article PubMed Google Scholar
11.Angioni S, D’alterio MN, Coiana A et al (2020) Genetic characterization of endometriosis patients: review of the literature and a prospective cohort study on a mediterranean population. Int J Mol Sci 21(5). https://doi.org/10.3390/ijms21051765
12.Viganó D, Zara F, Pinto S et al (2020) How is small bowel permeability in endometriosis patients? A case control pilot study. Gynecol Endocrinol 36(11):1010–1014. https://doi.org/10.1080/09513590.2020.1766440
CAS Article PubMed Google Scholar
13.Murgia F, Angioni S, D’Alterio MN et al (2021) Metabolic profile of patients with severe endometriosis: a prospective experimental study. Reprod Sci 28(3):728–735. https://doi.org/10.1007/s43032-020-00370-9
CAS Article PubMed Google Scholar
14.Triolo O, Laganà AS, Sturlese E (2013) Chronic pelvic pain in endometriosis: an overview. J Clin Med Res 5(3):153–163. https://doi.org/10.4021/jocmr1288w
CAS Article PubMed PubMed Central Google Scholar
15.Angioni S, Cofelice V, Sedda F et al (2015) Progestins for symptomatic endometriosis: results of clinical studies. Curr Drug Ther 10(2):91–104. https://doi.org/10.2174/157488551002151222160051
16.Jia SZ, Leng JH, Shi JH et al (2012) Health-related quality of life in women with endometriosis: a systematic review. J Ovarian Res 5(1). https://doi.org/10.1186/1757-2215-5-29
17.Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS (2017) Impact of endometriosis on quality of life and psychological well-being. J Psychosom Obstet Gynecol 38(4):317–319. https://doi.org/10.1080/0167482X.2016.1244185
18.D’Alterio MN, D’Ancona G, Raslan M et al (2020) Management challenges of deep infiltrating endometriosis. Int J Fertil Steril. https://doi.org/10.22074/ijfs.2020.134689
19.Vignali M, Belloni GM, Pietropaolo G et al (2020) Effect of dienogest therapy on the size of the endometrioma. Gynecol Endocrinol. https://doi.org/10.1080/09513590.2020.1725965
20.Angioni S, Pontis A, Malune ME et al (2020) Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol 36(1):84–86. https://doi.org/10.1080/09513590.2019.1640674
21.Melis GB, Neri M, Corda V et al (2016) Overview of elagolix for the treatment of endometriosis. Expert Opin Drug Metab Toxicol 12(5):581–588. https://doi.org/10.1517/17425255.2016.1171316
CAS Article PubMed Google Scholar
22.Alessandro P, Luigi N, Felice S et al (2017) Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature. Arch Gynecol Obstet 295(4):827–832. https://doi.org/10.1007/s00404-017-4328-6
CAS Article PubMed Google Scholar
23.Parazzini F, Viganò P, Candiani M, Fedele L (2013) Diet and endometriosis risk: a literature review. Reprod BioMed Online 26(4):323–336. https://doi.org/10.1016/j.rbmo.2012.12.011
24.Stochino-Loi E, Pontis A, Cofelice V et al (2019) Effect of ultramicronized-palmitoylethanolamide and co-micronizedpalmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: an open-label pilot study. Int J Women's Health 11:443–449. https://doi.org/10.2147/IJWH.S204275
25.Endometriosis Treatment Italian Club (ETIC) (2019, 2019) When more is not better: 10 “Don’ts” in endometriosis management. An ETIC position statement. Hum Reprod Open (3):hoz009. https://doi.org/10.1093/HROPEN/HOZ009
26.Angioni S, Pontis A, Cela V et al (2015) Surgical technique of endometrioma excision impacts on the ovarian reserve. Single-port access laparoscopy versus multiport access laparoscopy: a case control study. Gynecol Endocrinol 31(6):454–457. https://doi.org/10.3109/09513590.2015.1017812
27.Nappi L, Angioni S, Sorrentino F et al (2016) Anti-Mullerian hormone trend evaluation after laparoscopic surgery of monolateral endometrioma using a new dual wavelengths laser system (DWLS) for hemostasis. Gynecol Endocrinol 32(1):34–37. https://doi.org/10.3109/09513590.2015.1068754
CAS Article PubMed Google Scholar
28.The WHOQOL Group (1993) Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res 2(2):153–159. https://doi.org/10.1007/BF00435734
29.Cagnacci A, Della Vecchia E, Xholli A (2019) Chronic pelvic pain improvement: impact on quality of life and mood. Gynecol Endocrinol 35(6):502–505. https://doi.org/10.1080/09513590.2018.1540571
CAS Article PubMed Google Scholar
30.Eriksen HLF, Gunnersen KF, Sørensen JA et al (2008) Psychological aspects of endometriosis: differences between patients with or without pain on four psychological variables. Eur J Obstet Gynecol Reprod Biol 139(1):100–105. https://doi.org/10.1016/j.ejogrb.2007.10.002
31.Tripoli TM, Sato H, Sartori MG et al (2011) Evaluation of quality of life and sexual satisfaction in women suffering from chronic pelvic pain with or without endometriosis. J Sex Med 8(2):497–503. https://doi.org/10.1111/j.1743-6109.2010.01976.x
32.Denny E (2009) “I never know from one day to another how I will feel”: pain and uncertainty in women with endometriosis. Qual Health Res 19(7):985–995. https://doi.org/10.1177/1049732309338725
33.Facchin F, Barbara G, Saita E et al (2015) Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynecol 36(4):135–141. https://doi.org/10.3109/0167482X.2015.1074173
34.Gao X, Yeh YC, Outley J et al (2006) Health-related quality of life burden of women with endometriosis: a literature review. Curr Med Res Opin 22(9):1787–1797. https://doi.org/10.1185/030079906X121084
35.Marinho MCP, Magalhaes TF, Fernandes LFC et al (2018) Quality of life in women with endometriosis: an integrative review. J Women's Health 27(3):399–408. https://doi.org/10.1089/jwh.2017.6397
36.Bourdel N, Chauvet P, Billone V et al (2019) Systematic review of quality of life measures in patients with endometriosis. PLoS One 14(1):e0208464. https://doi.org/10.1371/journal.pone.0208464
CAS Article PubMed PubMed Central Google Scholar
37.Ware JEJ, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483
38.Stull DE, Wasiak R, Kreif N et al (2014) Validation of the SF-36 in patients with endometriosis. Qual Life Res 23(1):103–117. https://doi.org/10.1007/s11136-013-0442-5
39.Gandek B, Ware JE, Aaronson NK et al (1998) Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project. J Clin Epidemiol 51(11):1171–1178. https://doi.org/10.1016/S0895-4356(98)00109-7
CAS Article PubMed Google Scholar
40.Jones G, Jenkinson C, Kennedy S (2004) Evaluating the responsiveness of the endometriosis health profile questionnaire: the EHP-30. Qual Life Res 13(3):705–713. https://doi.org/10.1023/B:QURE.0000021316.79349.af
41.Jones G, Jenkinson C, Kennedy S (2004) Development of the short form endometriosis health profile questionnaire: the EHP-5. Qual Life Res 13(3):695–704. https://doi.org/10.1023/B:QURE.0000021321.48041.0e
42.Skevington SM, Bradshaw J, Saxena S (1999) Selecting national items for the WHOQOL: conceptual and psychometric considerations. Soc Sci Med 48(4):473–487. https://doi.org/10.1016/S0277-9536(98)00355-4
CAS Article PubMed Google Scholar
43.Skevington SM, Carse MS, De C, Williams AC (2001) Validation of the WHOQOL-100: pain management improves quality of life for chronic pain patients. Clin J Pain 17(3):264–275. https://doi.org/10.1097/00002508-200109000-00013
CAS Article PubMed Google Scholar
44.Balestroni G, Bertolotti G (2012) EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Arch Chest Dis - Card Ser 78(3):155–159. https://doi.org/10.4081/monaldi.2012.121
45.Moher D, Shamseer L, Clarke M et al (2016) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Rev Esp Nutr Humana y Diet 20(2):148–160. https://doi.org/10.1186/2046-4053-4-1
Comments (0)